The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESH 2017 | The benefits of patient advocacy groups
Patient advocacy groups can be of great use to patients, giving them means to network with other patients and providing a direct source of information. In this interview, recorded at the International Conference on Acute Myeloid Leukaemia 2017, by the European School of Hematology (ESH), in Estoril, Portugal, Jane Churpek, MD, of the University of Chicago, Chicago, IL, highlights some of benefits brought about by the formation of a patient advocacy group for patients diagnosed with familial platelet disorder.
